Standpoint Research raised its price target on Pfizer (NYSE: PFE) for 2010 and 2011 to $24 and $28 respectively, while ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE